Rani Therapeutics Holdings, Inc. - Class A Common Stock, Par Value $.0001 (RANI)
CUSIP: 753018100
Q4 2021 13F Holders as of 31 Dec 2021
- Type / Class
- Equity / Class A Common Stock, Par Value $.0001
- Shares outstanding
- 98,437,808
- Total 13F shares
- 1,240,919
- Share change
- +41,618
- Total reported value
- $20,288,000
- Price per share
- $16.35
- Number of holders
- 21
- Value change
- +$544,189
- Number of buys
- 14
- Number of sells
- 5
Quarterly Holders Quick Answers
What is CUSIP 753018100?
CUSIP 753018100 identifies RANI - Rani Therapeutics Holdings, Inc. - Class A Common Stock, Par Value $.0001 in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 753018100:
Top shareholders of RANI - Rani Therapeutics Holdings, Inc. - Class A Common Stock, Par Value $.0001 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Isidoro Quiroga Moreno |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
19,890,581
|
$45,151,619 | — | 30 Jul 2021 | |
| Nan Fung Group Holdings Ltd |
13F
|
Company |
0.5%
|
493,584
|
$8,796,000 | — | 30 Sep 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.29%
|
283,213
|
$5,047,000 | — | 30 Sep 2021 | |
| CAAS CAPITAL MANAGEMENT LP |
13F
|
Company |
0.08%
|
75,000
|
$1,337,000 | — | 30 Sep 2021 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.06%
|
60,649
|
$1,081,000 | — | 30 Sep 2021 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.05%
|
50,000
|
$891,000 | — | 30 Sep 2021 | |
| STIFEL FINANCIAL CORP |
13F
|
Company |
0.04%
|
37,950
|
$676,000 | — | 30 Sep 2021 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.03%
|
28,996
|
$517,000 | — | 30 Sep 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.02%
|
21,639
|
$385,000 | — | 30 Sep 2021 | |
| STATE STREET CORP |
13F
|
Company |
0.02%
|
19,700
|
$351,000 | — | 30 Sep 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.01%
|
11,430
|
$204,000 | — | 30 Sep 2021 | |
| Canton Hathaway, LLC |
13F
|
Company |
0.01%
|
10,000
|
$178,000 | — | 30 Sep 2021 | |
| UBS Group AG |
13F
|
Company |
0%
|
3,070
|
$55,000 | — | 30 Sep 2021 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
1,467
|
$26,000 | — | 30 Sep 2021 | |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO |
13F
|
Company |
0%
|
1,000
|
$18,000 | — | 30 Sep 2021 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
40
|
$1,000 | — | 30 Sep 2021 |
Institutional Holders of Rani Therapeutics Holdings, Inc. - Class A Common Stock, Par Value $.0001 (RANI) as of Q4 2021
As of 31 Dec 2021,
Rani Therapeutics Holdings, Inc. - Class A Common Stock, Par Value $.0001 (RANI) was held by
21 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,240,919 shares.
The largest 10 holders included
Nan Fung Group Holdings Ltd, VANGUARD GROUP INC, BlackRock Inc., Alpha Square Group S, LLC, GEODE CAPITAL MANAGEMENT, LLC, Squarepoint Ops LLC, STIFEL FINANCIAL CORP, ADVISOR GROUP HOLDINGS, INC., STATE STREET CORP, and CAAS CAPITAL MANAGEMENT LP.
This page lists
21
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2021 vs Q3 2021 Across Filers
Q3 2021 holders
14
Q4 2021 holders
21
Holder diff
7
| Investor | Q3 2021 Shares | Q4 2021 Shares | Share Diff | Share Chg % | Q3 2021 Value $ | Q4 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.